- Home
- LPTX vs FEBO Comparison
LPTX vs FEBO Comparison
Compare LPTX & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- FEBO
- Stock Information
- Founded
- LPTX 2011
- FEBO 1993
- Country
- LPTX United States
- FEBO Hong Kong
- Employees
- LPTX N/A
- FEBO N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- FEBO
- Sector
- LPTX Health Care
- FEBO
- Exchange
- LPTX Nasdaq
- FEBO Nasdaq
- Market Cap
- LPTX 14.7M
- FEBO 12.6M
- IPO Year
- LPTX N/A
- FEBO 2023
- Fundamental
- Price
- LPTX $0.35
- FEBO $1.11
- Analyst Decision
- LPTX Hold
- FEBO
- Analyst Count
- LPTX 1
- FEBO 0
- Target Price
- LPTX N/A
- FEBO N/A
- AVG Volume (30 Days)
- LPTX 3.3M
- FEBO 20.5K
- Earning Date
- LPTX 08-11-2025
- FEBO 07-29-2025
- Dividend Yield
- LPTX N/A
- FEBO N/A
- EPS Growth
- LPTX N/A
- FEBO N/A
- EPS
- LPTX N/A
- FEBO N/A
- Revenue
- LPTX N/A
- FEBO $17,110,653.00
- Revenue This Year
- LPTX N/A
- FEBO N/A
- Revenue Next Year
- LPTX N/A
- FEBO N/A
- P/E Ratio
- LPTX N/A
- FEBO N/A
- Revenue Growth
- LPTX N/A
- FEBO 11.58
- 52 Week Low
- LPTX $0.22
- FEBO $0.82
- 52 Week High
- LPTX $4.79
- FEBO $15.48
- Technical
- Relative Strength Index (RSI)
- LPTX 52.39
- FEBO 53.88
- Support Level
- LPTX $0.32
- FEBO $0.95
- Resistance Level
- LPTX $0.36
- FEBO $1.07
- Average True Range (ATR)
- LPTX 0.03
- FEBO 0.10
- MACD
- LPTX 0.01
- FEBO 0.01
- Stochastic Oscillator
- LPTX 86.94
- FEBO 63.36
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.